CellPoint B.V.
  • Home
  • About us
  • Technology
  • News
  • Careers
  • Contact

News

HomeAll PostsNews
  • Home
  • About us
  • Technology
  • News
  • Careers
  • Contact

Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies

News 23. June 2022

Mechelen, Belgium, Leiden, the Netherlands, Pittsburgh, Pennsylvania, United States; 21 June 2022, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG), CellPoint and AboundBio today announced that…

CellPoint and Hypertrust co-develop xCellit platform for cell therapies at the point of care

News 10. November 2021

CELlPOINT AND HYPERTRUST CO-DEVELOP xCELLIT platform for cell therapies at the point of care Leiden (NL) / Munich (DE) – November 2021 – CellPoint and Hypertrust Patient Data Care…

CellPoint and Lonza Enter Strategic Collaboration to Deliver CAR-T
Cells to Patients at Point-of-Care

News 23. June 2021

CellPoint and Lonza Enter Strategic Collaboration to Deliver CAR-T Cells to Patients at Point-of-Care Goal to rapidly develop several T-cell therapies on the Cocoon® Platform for clinical point-of-care manufacturing. Aims…

The future of cell therapy is at the point-of-care

Contact's logo
Address

BioPartner 5

De Limes 7

2342 DH Oegstgeest 

The Netherlands

Contact
info@cellpoint.bio+31 712077810
Information
  • Privacy Policy

© CellPoint – All Rights Reserved